ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms

Publication date: May 2019Source: Journal of the American College of Radiology, Volume 16, Issue 5, SupplementAuthor(s): Expert Panel on Women’s Imaging:, Mostafa Atri, Abdullah Alabousi, Caroline Reinhold, Esma A. Akin, Carol B. Benson, Priyadarshani R. Bhosale, Stella K. Kang, Yulia Lakhman, Refky Nicola, Pari V. Pandharipande, Maitray D. Patel, Gloria M. Salazar, Thomas D. Shipp, Lynn Simpson, Betsy L. Sussman, Jennifer W. Uyeda, Darci J. Wall, Bradford P. Whitcomb, Carolyn M. Zelop, Phyllis GlancAbstractThere are approximately 9.1 pelvic surgeries performed for every histologically confirmed adnexal malignancy in the United States, compared to 2.3 surgeries per malignancy (in oncology centers) and 5.9 surgeries per malignancy (in other centers) in Europe. An important prognostic factor in the long-term survival in patients with ovarian malignancy is the initial management by a gynecological oncologist. With high accuracy of imaging for adnexal mass characterization and consequent appropriate triage to subspecialty referral, the better use of gynecologic oncology can improve treatment outcomes. Ultrasound, including transabdominal, transvaginal, and duplex ultrasound, combined with MRI with contrast can diagnose adnexal masses as benign with specific features (ie, functional masses, dermoid, endometrioma, fibroma, pedunculated fibroid, hydrosalpinx, peritoneal inclusion cyst, Tarlov cyst), malignant, or indeterminate.The American College of Radiology Appropriateness Crit...
Source: Journal of the American College of Radiology - Category: Radiology Source Type: research